ARTICLE | Financial News
Abbisko completes venture financing
February 10, 2017 8:43 PM UTC
Cancer company Abbisko Therapeutics (Shanghai, China) raised $28 million in a series A round from Lilly Asia Ventures, Sinopharm Capital, Jianxin Capital and TF Capital on Feb. 5....